GSK plc Share Purchases and Treasury Holdings Update

GSK plc has announced the completion of several ordinary share purchases through its broker, Citigroup Global Markets Limited, between June 8th and June 12th, 2026. These transactions were part of the company's ongoing buyback program, initiated under a non-discretionary agreement established on May 8th, 2026. A total of 7,346,236 ordinary shares have been repurchased since May 11th, 2026. Following these purchases, GSK plc will hold 268,724,522 shares in treasury, with 4,047,527,077 ordinary shares remaining in issue. The company also confirmed that the percentage of voting rights held in treasury is 6.64%, a figure shareholders can use for notification calculations regarding their interests. Detailed transaction information is available via a provided link. GSK plc, a global biopharma company, is focused on uniting science, technology, and talent to combat disease.